Dickkopf-3 contributes to the regulation of anti-tumor immune responses by mesenchymal stem cells

Frontiers in Immunology

Volumn 6, Issue DEC, 2015, Pages

  Lu, Kun Hui ^a   Tounsi, Amel ^a   Shridhar, Naveen ^b   Küblbeck, Günter ^a   Klevenz, Alexandra ^a   Prokosch, Sandra ^a   Bald, Tobias ^b   Tüting, Thomas ^b   Arnold, Bernd ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Anti tumor response; Dickkopf 3; Melanoma; Mesenchymal stem cell; T cell; Tumor stroma

Indexed keywords

DICKKOPF 3 PROTEIN; GLYCOPROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR IMMUNITY; WESTERN BLOTTING;

EID: 84954217707     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00645     Document Type: Article

References (41)

1. Zhao S, Wehner R, Bornhauser M, Wassmuth R, Bachmann M, Schmitz M. Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders. Stem Cells Dev (2010) 19(5):607-14. doi: 10.1089/scd.2009.0345.
2. Singer NG, Caplan AI. Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol (2011) 6:457-78. doi:10.1146/annurev-pathol-011110-130230.
3. Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol (2012) 12(5):383-96. doi:10.1038/nri3209.
4. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet (2004) 363(9419):1439-41. doi:10.1016/S0140-6736(04)16104-7.
5. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood (2005) 106(5):1755-61. doi:10.1182/blood-2005-04-1496.
6. Su WR, Zhang QZ, Shi SH, Nguyen AL, Le AD. Human gingiva-derived mesenchymal stromal cells attenuate contact hypersensitivity via prostaglandin E2-dependent mechanisms. Stem Cells (2011) 29(11):1849-60. doi:10.1002/stem.738.
7. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood (2003) 101(9):3722-9. doi:10.1182/blood-2002-07-2104.
8. Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood (2005) 105(7):2821-7. doi:10.1182/blood-2004-09-3696.
9. Patel SA, Meyer JR, Greco SJ, Corcoran KE, Bryan M, Rameshwar P. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta. J Immunol (2010) 184(10):5885-94. doi:10.4049/jimmunol.0903143.
10. Maggini J, Mirkin G, Bognanni I, Holmberg J, Piazzon IM, Nepomnaschy I, et al. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One (2010) 5(2):e9252. doi:10.1371/journal.pone.0009252.
11. Ghannam S, Pene J, Moquet-Torcy G, Jorgensen C, Yssel H. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. J Immunol (2010) 185(1):302-12. doi:10.4049/jimmunol.0902007.
12. Duffy MM, Pindjakova J, Hanley SA, McCarthy C, Weidhofer GA, Sweeney EM, et al. Mesenchymal stem cell inhibition of T-helper 17 cell-differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor. Eur J Immunol (2011) 41(10):2840-51. doi:10.1002/eji.201141499.
13. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood (2004) 103(12):4619-21. doi:10.1182/blood-2003-11-3909.
14. Opitz CA, Litzenburger UM, Lutz C, Lanz TV, Tritschler I, Koppel A, et al. Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R. Stem Cells (2009) 27(4):909-19. doi:10.1002/stem.7.
15. Niehrs C. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene (2006) 25(57):7469-81. doi:10.1038/sj.onc.1210054.
16. Veeck J, Dahl E. Targeting the Wnt pathway in cancer: the emerging role of Dickkopf-3. Biochim Biophys Acta (2012) 1825(1):18-28. doi:10.1016/j.bbcan.2011.09.003.
17. Barrantes Idel B, Montero-Pedrazuela A, Guadano-Ferraz A, Obregon MJ, Martinez de Mena R, Gailus-Durner V, et al. Generation and characterization of Dickkopf3 mutant mice. Mol Cell Biol (2006) 26(6):2317-26. doi:10.1128/MCB.26.6.2317-2326.2006.
18. Song L, Webb NE, Song Y, Tuan RS. Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency. Stem Cells (2006) 24(7):1707-18. doi:10.1634/stemcells.2005-0604.
19. Lee RH, Yoon N, Reneau JC, Prockop DJ. Preactivation of human MSCs with TNF-alpha enhances tumor-suppressive activity. Cell Stem Cell (2012) 11(6):825-35. doi:10.1016/j.stem.2012.10.001.
20. Papatriantafyllou M, Moldenhauer G, Ludwig J, Tafuri A, Garbi N, Hollmann G, et al. Dickkopf-3, an immune modulator in peripheral CD8 T-cell tolerance. Proc Natl Acad Sci U S A (2012) 109(5):1631-6. doi:10.1073/pnas.1115980109.
21. Meister M, Papatriantafyllou M, Nordstrom V, Kumar V, Ludwig J, Lui KO, et al. Dickkopf-3, a tissue-derived modulator of local T-cell responses. Front Immunol (2015) 6:78. doi:10.3389/fimmu.2015.00078.
22. Meister M, Tounsi A, Gaffal E, Bald T, Papatriantafyllou M, Ludwig J, et al. Self-antigen presentation by keratinocytes in the inflamed adult skin modulates T-cell auto-reactivity. J Invest Dermatol (2015) 135(8):1996-2004. doi:10.1038/jid.2015.130.
23. Ludwig J, Federico G, Prokosch S, Kublbeck G, Schmitt S, Klevenz A, et al. Dickkopf-3 acts as a modulator of B cell fate and function. J Immunol (2015) 194(6):2624-34. doi:10.4049/jimmunol.1402160.
24. Nadri S, Soleimani M, Hosseni RH, Massumi M, Atashi A, Izadpanah R. An efficient method for isolation of murine bone marrow mesenchymal stem cells. Int J Dev Biol (2007) 51(8):723-9. doi:10.1387/ijdb.072352ns.
25. Soleimani M, Nadri S. A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc (2009) 4(1):102-6. doi:10.1038/nprot.2008.221.
26. Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol (1989) 24(3):148-54. doi:10.1007/BF00300234.
27. Ronchetti A, Iezzi G, Crosti MC, Garancini MP, Protti MP, Bellone M. Role of antigen-presenting cells in cross-priming of cytotoxic T lymphocytes by apoptotic cells. J Leukoc Biol (1999) 66(2):247-51.
28. Klopp AH, Gupta A, Spaeth E, Andreeff M, Marini F III. Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem Cells (2011) 29(1):11-9. doi:10.1002/stem.559.
29. Anderson P, Carrillo-Galvez AB, Garcia-Perez A, Cobo M, Martin F. CD105 (endoglin)-negative murine mesenchymal stromal cells define a new multipotent subpopulation with distinct differentiation and immunomodulatory capacities. PLoS One (2013) 8(10):e76979. doi:10.1371/journal.pone.0076979.
30. Kataoka K, Sakaguchi M, Li KP, Taketa C, Yamamoto K, Du G, et al. Internalization of REIC/Dkk-3 protein by induced pluripotent stem cell-derived embryoid bodies and extra-embryonic tissues. Int J Mol Med (2010) 26(6):853-9. doi:10.3892/ijmm_00000534.
31. Lee EJ, Jo M, Rho SB, Park K, Yoo YN, Park J, et al. Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin. Int J Cancer (2009) 124(2):287-97. doi:10.1002/ijc.23913.
32. Gattinoni L, Zhong XS, Palmer DC, Ji Y, Hinrichs CS, Yu Z, et al. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat Med (2009) 15(7):808-13. doi:10.1038/nm.1982.
33. van Loosdregt J, Fleskens V, Tiemessen MM, Mokry M, van Boxtel R, Meerding J, et al. Canonical Wnt signaling negatively modulates regulatory T cell function. Immunity (2013) 39(2):298-310. doi:10.1016/j.immuni.2013.07.019.
34. Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y, Namba M. A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem Biophys Res Commun (2000) 268(1):20-4. doi:10.1006/bbrc.1999.2067.
35. Nozaki I, Tsuji T, Iijima O, Ohmura Y, Andou A, Miyazaki M, et al. Reduced expression of REIC/Dkk-3 gene in non-small cell lung cancer. Int J Oncol (2001) 19(1):117-21. doi:10.3892/ijo.19.1.117.
36. Veeck J, Wild PJ, Fuchs T, Schuffler PJ, Hartmann A, Knuchel R, et al. Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer. BMC Cancer (2009) 9:217. doi:10.1186/1471-2407-9-217.
37. Xiang T, Li L, Yin X, Zhong L, Peng W, Qiu Z, et al. Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/beta-catenin signalling and apoptosis regulation in breast cancer cells. J Cell Mol Med (2013) 17(10):1236-46. doi:10.1111/jcmm.12099.
38. Yu J, Tao Q, Cheng YY, Lee KY, Ng SS, Cheung KF, et al. Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer. Cancer (2009) 115(1):49-60. doi:10.1002/cncr.23989.
39. Kuphal S, Lodermeyer S, Bataille F, Schuierer M, Hoang BH, Bosserhoff AK. Expression of Dickkopf genes is strongly reduced in malignant melanoma. Oncogene (2006) 25(36):5027-36. doi:10.1038/sj.onc.1209508.
40. Katase N, Gunduz M, Beder L, Gunduz E, Lefeuvre M, Hatipoglu OF, et al. Deletion at Dickkopf (dkk)-3 locus (11p15.2) is related with lower lymph node metastasis and better prognosis in head and neck squamous cell carcinomas. Oncol Res (2008) 17(6):273-82. doi:10.3727/096504008786991594.
41. Hirata T, Watanabe M, Kaku H, Kobayashi Y, Yamada H, Sakaguchi M, et al. REIC/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer. Int J Oncol (2012) 41(2):559-64. doi:10.3892/ijo.2012.1503.